Doylestown, PA (PRWEB) August 17, 2012
Why do smart executives make such poor decisions when it comes to project selection? This is the central question asked and answered by author Michael Menard in “A Fish in Your Ear: The New Discipline of Project Portfolio Management” (ISBN 1475299354). Despite having a wealth of experience, education and knowledge under their belts, many managers make project selection mistakes that cost their companies profits, respect and morale.
“Project selection is the most important, yet the least understood aspect of business today,” says Menard. “I want ‘A Fish in Your Ear’ to enlighten managers at all levels on what is important when it comes to project selection, and the hidden value it can deliver to organizations.”
Beginning with the informative and entertaining evolution of human cognition and decision-making, Michael Menard offers a uniquely effective and proven guide to business process design, technology, and organizational change required to create Capital Efficient Profitable Growth.
As a former senior executive with Johnson & Johnson and as an advisor for many major international organizations like Coca-Cola and the US Department of Energy, the author has seen what works and what doesn’t when selecting portfolios of projects. He also sheds light on how the current economic environment is sending leaders “to the bunkers.”
“A Fish in Your Ear: The New Discipline of Project Portfolio Management” is available at Amazon.com and other online retailers. For more information, please visit http://www.afishinyourear.com.
About the Author
Michael Menard is cofounder and president of The GenSight Group, which provides enterprise portfolio management solutions for strategic planning, project portfolio management and business performance optimization. He has contributed to numerous professional publications including Harvard Management Update, Gartner Research, and The Journal of the American Management Association. Menard was previously a senior executive at Johnson & Johnson and is holder of 14 US patents. He has advised senior executives at organizations including Coca-Cola, Johnson and Johnson, Cisco, Pfizer, Glaxo, Westinghouse Nuclear and the US Department of Energy.
To schedule an interview with Mike or request a review copy of the book, please contact:
PR/PR Public Relations